1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. PUMA BIOTECHNOLOGY INC
Puma Biotechnology Inc XNAS: PBYI

Puma biotech Inc Live Stock Price Today, Share Analysis and Chart

Strong Performer
about

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for t...

Read More
7.11 0.28 (4.10%)
Near 52W High of $7.28
451.3K
XNAS Volume

XNAS 23 Feb, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Puma biotech Inc is on 27 Feb 2026 for the purpose of Puma Biotechnology Inc Fourth Quarter Earnings Results for 2025 See details
Durability score
High Financial Strength
66.7 / 100
Valuation Score
Affordable Valuation
57.8 / 100
Momentum Score
Technically Moderately Bullish
62.6 / 100
Strong Performer These stock companies have strong financials and are affordably priced. They also score high in quality and technical metrics which make them popular with investors View Similar Embed DVM
Analyst Price Target
5
1Yr Price target downside is -30%
1 analysts

27

S

4

W

6

O

0

T

SWOT Analysis

Puma biotech Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..